Showing results (1151-1160 of 1,902) with videos related to
Sort By:
Pageof 191
European Review for Medical and Pharmacological Sciences|June 16, 2017
Cervicovaginal bacteria and fungi in pregnant diabetic and non-diabetic women: a multicenter observational cohort studyA Lukic, A Napoli, I Santino, et al.Journal of Prenatal Medicine|April 4, 2012
Prenatal diagnosis of genomic disorders and chromosome abnormalities using array-based comparative genomic hybridizationFrancesca Gullotta, Michela Biancolella, Elena Costa, et al.Multiple Sclerosis and Related Disorders|November 24, 2019
The impact of diagnostic criteria and treatments on the 20-year costs for treating relapsing-remitting multiple sclerosisMartina Petruzzo, Raffaele Palladino, Antonio Nardone, et al.Journal of Cancer Research and Clinical Oncology|April 4, 2025
Nuclear magnetic resonance-based lipid metabolite profiles for differentiation of patients with liver cirrhosis with and without hepatocellular carcinomaLuigi Nardone, Marianna Alunni-Fabbroni, Regina Schinner, et al.NPJ Breast Cancer|July 30, 2025
Single-cell transcriptomics reveals biomarker heterogeneity linked to CDK4/6 Inhibitor resistance in breast cancer cell linesIlenia Migliaccio, Martina Bonechi, Dario Romagnoli, et al.Disease Markers|November 1, 2017
Longitudinal Assessment of Transorbital Sonography, Visual Acuity, and Biomarkers for Inflammation and Axonal Injury in Optic NeuritisPiergiorgio Lochner, Roberto Cantello, Klaus Fassbender, et al.Endocrine|March 15, 2014
PTH-C1: a rat continuous cell line expressing the parathyroid phenotypeSergio Fabbri, Simone Ciuffi, Valeria Nardone, et al.Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|February 10, 2015
Lactobacillus paracasei F19 versus placebo for the prevention of proton pump inhibitor-induced bowel symptoms: a randomized clinical trialDebora Compare, Alba Rocco, Costantino Sgamato, et al.Diabetes Research and Clinical Practice|April 24, 2018
Everolimus is a new anti-cancer molecule: Metabolic side effects as lipid disorders and hyperglycemiaL Morviducci, F Rota, L Rizza, et al.Endocrine, Metabolic & Immune Disorders Drug Targets|August 28, 2024
Thyroid Hormone Resistance: A 17-Year Follow-up Case ReportCristina Giusto, Marina Passeri, Patrizia Sperti, et al.Pageof 191